X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (29) 29
female (25) 25
index medicus (22) 22
oncology (22) 22
middle aged (21) 21
adult (16) 16
aged (16) 16
male (16) 16
chemotherapy (13) 13
aged, 80 and over (11) 11
cancer (9) 9
neoplasm staging (9) 9
radiotherapy (9) 9
surgery (9) 9
breast neoplasms - pathology (8) 8
antineoplastic agents - therapeutic use (7) 7
breast cancer (7) 7
carcinoma, squamous cell - pathology (7) 7
head and neck neoplasms - pathology (7) 7
squamous-cell carcinoma (7) 7
survival (7) 7
treatment outcome (7) 7
tumors (7) 7
head and neck neoplasms - drug therapy (6) 6
head and neck neoplasms - radiotherapy (6) 6
metastasis (6) 6
article (5) 5
breast neoplasms - drug therapy (5) 5
carcinoma, squamous cell - mortality (5) 5
combined modality therapy (5) 5
head (5) 5
head and neck neoplasms - mortality (5) 5
hematology, oncology and palliative medicine (5) 5
locally advanced head (5) 5
mastectomy (5) 5
medicine & public health (5) 5
nccn clinical practice guidelines (5) 5
neck (5) 5
patients (5) 5
prognosis (5) 5
radiation-therapy (5) 5
randomized-trial (5) 5
therapy (5) 5
trial (5) 5
breast neoplasms - therapy (4) 4
carcinoma, squamous cell - radiotherapy (4) 4
care and treatment (4) 4
cetuximab (4) 4
chemoradiotherapy (4) 4
cisplatin (4) 4
disease-free survival (4) 4
endocrine therapy (4) 4
head and neck cancer (4) 4
larynx (4) 4
neoplasm metastasis (4) 4
radiation therapy (4) 4
radiology, nuclear medicine & medical imaging (4) 4
research (4) 4
retrospective studies (4) 4
squamous cell carcinoma (4) 4
squamous cell carcinoma of head and neck (4) 4
toxicity (4) 4
trastuzumab (4) 4
adjuvant therapy (3) 3
animals (3) 3
antibodies, monoclonal, humanized (3) 3
antineoplastic agents - adverse effects (3) 3
antineoplastic combined chemotherapy protocols - adverse effects (3) 3
antineoplastic combined chemotherapy protocols - therapeutic use (3) 3
breast neoplasms - genetics (3) 3
breast neoplasms - metabolism (3) 3
breast-conserving therapy (3) 3
carcinoma (3) 3
chemoradiation (3) 3
chemotherapy, adjuvant (3) 3
clinical trials (3) 3
combination (3) 3
ductal carcinoma in situ (3) 3
genetic counseling (3) 3
head and neck (3) 3
kaplan-meier estimate (3) 3
lobular carcinoma in situ (3) 3
multicenter (3) 3
neoplasm invasiveness (3) 3
neoplasm recurrence, local - mortality (3) 3
neoplasm recurrence, local - pathology (3) 3
otorhinolaryngology (3) 3
radiology (3) 3
radiology and nuclear medicine (3) 3
radiotherapy dosage (3) 3
young adult (3) 3
adolescent (2) 2
age factors (2) 2
analysis (2) 2
antibodies, monoclonal - therapeutic use (2) 2
antibody (2) 2
antimitotic agents (2) 2
antineoplastic agents (2) 2
antineoplastic agents - administration & dosage (2) 2
antineoplastic combined chemotherapy protocols - administration & dosage (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2009, Volume 73, Issue 2, pp. 410 - 415
Purpose The use of altered fractionation radiotherapy (RT) regimens, as well as concomitant chemotherapy and RT, to intensify therapy for locally advanced... 
Radiology | Hematology, Oncology and Palliative Medicine | Head and neck | Fractionation | Dysphagia | Aspiration | Chemoradiotherapy | IMRT | INTENSITY-MODULATED RADIOTHERAPY | SWALLOW FUNCTION | CHEMOTHERAPY | ONCOLOGY | REDUCE DYSPHAGIA | CHEMORADIATION | NUTRITION | QUALITY-OF-LIFE | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | Pneumonia, Aspiration - diagnosis | Constriction, Pathologic - etiology | Carcinoma, Squamous Cell - pathology | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Carcinoma, Squamous Cell - radiotherapy | Young Adult | Gastrostomy - utilization | Deglutition Disorders - diagnosis | Aged, 80 and over | Adult | Deglutition Disorders - etiology | Female | Esophageal Stenosis - etiology | Radiotherapy Dosage | Head and Neck Neoplasms - drug therapy | Tumor Burden | Combined Modality Therapy - adverse effects | Constriction, Pathologic - diagnosis | Pharyngeal Diseases - diagnosis | Head and Neck Neoplasms - pathology | Head and Neck Neoplasms - radiotherapy | Regression Analysis | Analysis of Variance | Adolescent | Pharyngeal Diseases - etiology | Aged | Esophageal Stenosis - diagnosis | Chemotherapy | Radiotherapy | Deglutition disorders | Cancer | Index Medicus | DIAGNOSIS | HEAD | PATIENTS | FRACTIONATION | ORAL CAVITY | RADIATION HAZARDS | RADIATION DOSES | PNEUMONIA | MULTIVARIATE ANALYSIS | BARIUM | CARCINOMAS | RADIOLOGY AND NUCLEAR MEDICINE | NECK | RADIOTHERAPY | COMBINED THERAPY
Journal Article
Future Oncology, ISSN 1479-6694, 07/2016, Volume 12, Issue 13, pp. 1595 - 1608
Integration and optimization of active systemic agents and radiosensitizers into the therapeutic regimen for head and neck cancer remains a topic of active... 
head and neck | chemoradiation | chemotherapy | ORAL-CAVITY | SALVAGE TOTAL LARYNGECTOMY | ADVANCED LARYNX CANCER | RADIATION-THERAPY | PHASE-III TRIAL | ORGAN PRESERVATION | ONCOLOGY | UNRESECTABLE HEAD | SQUAMOUS-CELL CARCINOMA | LOCALLY ADVANCED HEAD | DEFINITIVE CHEMORADIOTHERAPY
Journal Article
Human Pathology, ISSN 0046-8177, 2014, Volume 45, Issue 2, pp. 310 - 319
Journal Article
Radiation Oncology, ISSN 1748-717X, 12/2012, Volume 7, Issue 1, pp. 219 - 219
Background: The utility of definitive radiotherapy (RT) for locoregionally advanced squamous cell carcinoma (SCC) of the larynx or hypopharynx in the setting... 
Hypopharynx | Cartilage | Cricoid | Local failure | Head and neck | Larynx | Radiotherapy | Invasion | Cancer | Thyroid | SURVIVAL | RANDOMIZED-TRIAL | DOCETAXEL | CHEMOTHERAPY | PRESERVATION | CISPLATIN | ONCOLOGY | LOCALLY ADVANCED HEAD | BONE | SQUAMOUS-CELL CARCINOMAS | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | Laryngeal Neoplasms - radiotherapy | Prognosis | Carcinoma, Squamous Cell - pathology | Humans | Middle Aged | Tomography, X-Ray Computed - methods | Male | Hypopharyngeal Neoplasms - mortality | Carcinoma, Squamous Cell - radiotherapy | Laryngeal Neoplasms - pathology | Squamous Cell Carcinoma of Head and Neck | Carcinoma, Squamous Cell - mortality | Thyroid Cartilage - pathology | Aged, 80 and over | Adult | Female | Retrospective Studies | Databases, Factual | Thyroid Neoplasms - mortality | Treatment Outcome | Cricoid Cartilage - pathology | Head and Neck Neoplasms - pathology | Head and Neck Neoplasms - radiotherapy | Hypopharyngeal Neoplasms - radiotherapy | Laryngeal Neoplasms - mortality | Hypopharyngeal Neoplasms - pathology | Thyroid Neoplasms - secondary | Aged | Head and Neck Neoplasms - mortality | Care and treatment | Squamous cell carcinoma | Throat cancer | Laryngeal cancer | Departments | Medical imaging | Nuclear magnetic resonance--NMR | Colleges & universities | Otolaryngology | Oncology | Radiation therapy | Cancer therapies | Patients | Ovarian cancer | Chemotherapy | Surgery | Invasions | Tumors
Journal Article
Clinical Cancer Research, ISSN 1078-0432, 08/2015, Volume 21, Issue 16, pp. 3658 - 3666
Journal Article
Clinical Cancer Research, ISSN 1078-0432, 10/2013, Volume 19, Issue 19, pp. 5505 - 5512
Journal Article
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2013, Volume 85, Issue 5, pp. 1275 - 1281
Purpose To assess the toxicity profile of erlotinib therapy combined with postoperative adjuvant radiation therapy in patients with advanced cutaneous squamous... 
Radiology | Hematology, Oncology and Palliative Medicine | TRIAL | GROWTH-FACTOR RECEPTOR | CETUXIMAB | GEFITINIB | ONCOLOGY | CHEMORADIOTHERAPY | LOCALLY ADVANCED HEAD | RADIOTHERAPY | INHIBITOR | CANCER | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | Erlotinib Hydrochloride | Radiodermatitis | Prospective Studies | Carcinoma, Squamous Cell - pathology | Humans | Middle Aged | Male | Protein Kinase Inhibitors - adverse effects | Neoplasm Recurrence, Local - mortality | Neoplasm Recurrence, Local - pathology | Carcinoma, Squamous Cell - mortality | Radiotherapy, Adjuvant - adverse effects | Skin Neoplasms - mortality | Aged, 80 and over | Female | Radiotherapy Dosage | Skin Neoplasms - pathology | Skin Neoplasms - therapy | Neoplasm Recurrence, Local - therapy | Head and Neck Neoplasms - therapy | Carcinoma, Squamous Cell - therapy | Stomatitis - etiology | Head and Neck Neoplasms - pathology | Disease-Free Survival | Protein Kinase Inhibitors - therapeutic use | Quinazolines - therapeutic use | Radiotherapy, Adjuvant - methods | Quinazolines - adverse effects | Aged | Head and Neck Neoplasms - mortality | Neoplasm Staging | Medical research | Squamous cell carcinoma | Care and treatment | Erlotinib | Nuclear radiation | Medicine, Experimental | Radiotherapy | Cancer | Index Medicus | HEAD | PATIENTS | DIARRHEA | CARCINOMAS | RADIOLOGY AND NUCLEAR MEDICINE | TOXICITY | NECK
Journal Article
Journal Article
Future oncology (London, England), 07/2016, Volume 12, Issue 13, p. 1595
Integration and optimization of active systemic agents and radiosensitizers into the therapeutic regimen for head and neck cancer remains a topic of active... 
Humans | Head and Neck Neoplasms - drug therapy | Induction Chemotherapy - methods
Journal Article
Breast Cancer Research and Treatment, ISSN 0167-6806, 10/2018, Volume 171, Issue 3, pp. 637 - 648
Journal Article
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2008, Volume 71, Issue 3, pp. 676 - 681
Journal Article
Breast Cancer Research and Treatment, ISSN 0167-6806, 11/2014, Volume 148, Issue 1, pp. 99 - 106
Journal Article